The first of seven challenges for which Teva is seeking novel solutions revolves around human-predictive platforms for ...

The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) 2026 welcomes project leaders, procurement specialists and technical professionals from the whole value chain. On 20-21 April in ...

Pharmaceutical manufacturing sits at the intersection of science, technology, and global health—driving critical advances in how medicines are developed, produced, and delivered. News Medical has ...

AstraZeneca said on Friday it will invest $2 billion to expand its manufacturing footprint in Maryland as part of its ...

Eleva’s CEO says CHO cell line alternatives could become common as large molecule drugs become complex and harder to produce ...

Because scope 3 covers the entire value chain, pharma scientists should integrate sustainability into R&D, manufacturing, and sourcing strategies (6,7).

Andreas Eschbach is the founder and CEO of eschbach, a software company that helps production teams work smarter and enhance collaboration. The pharmaceutical industry stands at a critical juncture.

THE government has expressed its commitment to expanding investment opportunities in the pharmaceutical and medical equipment ...

LONDON--(BUSINESS WIRE)--The pharmaceutical manufacturing industry is considered one of the top 10 industries with the highest barriers to entry. Issues such as high R&D costs, challenging regulatory ...

Teva Pharmaceutical Industries said on Wednesday it was calling on startups to join its new platform to develop technologies ...

The one-year grace period for MSME drug manufacturers to comply with revised Schedule M norms has ended, with the CDSCO ...